- Home
- LUCD vs NCMI Comparison
LUCD vs NCMI Comparison
Compare LUCD & NCMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LUCD | NCMI |
|---|---|---|
| Founded | 2018 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Advertising |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 192.9M | 207.0M |
| IPO Year | 2021 | 2006 |
Fundamental Metrics
Financial Performance| Metric | LUCD | NCMI |
|---|---|---|
| Price | $0.64 | $2.13 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 4 |
| Target Price | $4.00 | ★ $4.75 |
| AVG Volume (30 Days) | ★ 1.5M | 1.2M |
| Earning Date | 11-11-2026 | 10-29-2026 |
| Dividend Yield | N/A | ★ 4.07% |
| EPS Growth | 16.67 | ★ 52.17 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,346,000.00 | N/A |
| Revenue This Year | $33.93 | $8.57 |
| Revenue Next Year | $165.18 | $3.59 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 79.00 | N/A |
| 52 Week Low | $0.50 | $1.99 |
| 52 Week High | $1.63 | $4.56 |
Technical Indicators
Market Signals| Indicator | LUCD | NCMI |
|---|---|---|
| Relative Strength Index (RSI) | 33.10 | 36.75 |
| Support Level | $0.50 | N/A |
| Resistance Level | $1.09 | $2.33 |
| Average True Range (ATR) | 0.07 | 0.12 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 35.14 | 43.48 |
Price Performance
Historical ComparisonAbout LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
About NCMI National CineMedia Inc.
National CineMedia Inc is a cinema advertising platform in the U.S. It derives revenue from the sale of advertising to national, regional and local businesses through The Noovie Show and the CineLife Show, the cinema advertising and entertainment show seen on movie screens across the U.S., on LEN, a series of strategically-placed screens located in movie theater lobbies, as well as other forms of advertising and promotions in theater lobbies.